Interventions for chronic kidney disease in people with sickle cell disease.

Roy, Noemi Ba; Fortin, Patricia M; Bull, Katherine R; Doree, Carolyn; Trivella, Marialena; Hopewell, Sally; Estcourt, Lise J

Roy, Noemi Ba; Fortin, Patricia M; Bull, Katherine R; Doree, Carolyn; Trivella, Marialena; Hopewell, Sally; Estcourt, Lise J.

Afiliación

Roy NB; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Fortin PM; Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Bull KR; Oxford Kidney Unit and Nuffield Department of Medicine, Oxford University Hospitals Trust and the University of Oxford, Oxford, UK.
Doree C; Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Trivella M; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Hopewell S; Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.
Estcourt LJ; Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.

Cochrane Database Syst Rev ; 2016(10)2016 Oct.

Article en En | MEDLINE | ID: mdl-28344511

RESUMEN

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of any intervention in preventing or reducing kidney complications or CKD in people with SCD (including red blood cell transfusions, hydroxyurea and ACEI (either alone or in combination with each other)).

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cochrane Database Syst Rev Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google